NCT04447196

Brief Summary

Congenital central hypoventilation syndrome (CCHS) is a neuro-respiratory disease characterized by lifethreatening sleep-related hypoventilation involving an alteration of CO2/H+ chemosensitivity. This suggests cortical activity during awakening to maintain breathing. Cortical activity to keep breathing is usually associated with breathing discomfort ; this is the case in healthy subjects under non invasive ventilation (NIV) or with expiratory charge as well as in patients with amyotrophic lateral sclerosis. This can suggest that CCHS may be breathless at rest and this discomfort could be reduced by NIV. The objective is to evaluate dyspnea with a multi dimensional score, MDP, in CCHS patient at rest in every day life and during 1H session of NIV. The investigators will perform a prospective, including 20 CCHS patients. MDP scores will be measure before and after 1H-non invasive ventilation as well as a visual scale of 100mm in order to evaluate variation of breathing discomfort before/after NIV. The investigators expect that CCHS patients don't have rest dyspnea but NIV would improve breathing discomfort that would mean they have latent rest dyspnea.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Dec 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 30, 2020

Completed
26 days until next milestone

First Posted

Study publicly available on registry

June 25, 2020

Completed
1.5 years until next milestone

Study Start

First participant enrolled

December 15, 2021

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2022

Completed
Last Updated

July 12, 2021

Status Verified

July 1, 2021

Enrollment Period

10 months

First QC Date

May 30, 2020

Last Update Submit

July 9, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • "Immediate unpleasantness" corresponding to A.1 item of the multidimensional dyspnea profile

    Measure MDP scores before and after NIV

    Change in MDP score between baseline and after 1 hour of NIV

Study Arms (1)

CCHS

20 patients presenting with central hypoventilation syndrome during spontaneous breathing and with Non Invasive Ventilation

Other: MDP

Interventions

MDPOTHER

Multi dimensional dyspnea profile scores at rest and during non invasive ventilation

CCHS

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adults with CCHS who already require long terme NIV but not phrenic nerve stimulation

You may qualify if:

  • patients with CCHS confirmed by genetic test
  • patients with long term non invasive ventilation
  • no recent condition that could impact breathing sensations such as infection, pulmonary embolism, heart failure

You may not qualify if:

  • pregnancy
  • phrenic nerve stimulation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

INSERM-UPC UMR_S 1158, Service de Pneumologie et Réanimation, GH Pitié-Salpêtrière

Paris, 75013, France

Location

MeSH Terms

Conditions

Congenital central hypoventilation syndromeDyspnea

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract DiseasesSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 30, 2020

First Posted

June 25, 2020

Study Start

December 15, 2021

Primary Completion

October 1, 2022

Study Completion

October 1, 2022

Last Updated

July 12, 2021

Record last verified: 2021-07

Locations